Showing results (1621-1630 of 1,823) with videos related to

Sort By:
Pageof 183
Transplantation and Cellular Therapy|February 14, 2026
Long-term follow-up after mixed donor myeloid chimerism at 1 year post transplantation for sickle cell diseaseGregory M T Guilcher, Stuti Dalal, Tara Suresh, et al.
Transplantation and Cellular Therapy|August 23, 2025
HCT-VTE-J Model to Predict Late-Onset Venous Thromboembolism after Allogeneic Hematopoietic Stem Cell Transplantation: A Japanese Single-Center StudyShuhei Kurosawa, Kana Kato, Yasutaka Sadaga, et al.
Transplantation and Cellular Therapy|April 11, 2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group ReportCarrie L Kitko, Joseph Pidala, Hélène M Schoemans, et al.
Transplantation and Cellular Therapy|April 15, 2021
Nonmyeloablative Conditioning Regimen Including Low-Dose Total Marrow/Lymphoid Irradiation Before Haploidentical Transplantation with Post-Transplantation Cyclophosphamide in Patients with Advanced Lymphoproliferative DiseasesBarbara Sarina, Pietro Mancosu, Pierina Navarria, et al.
Transplantation and Cellular Therapy|April 15, 2021
Hematopoietic Stem Cell Transplantation in T Cell and Natural Killer Cell Lymphomas: Update on Recent AdvancesYang Liang Boo, Liang Piu Koh
Transplantation and Cellular Therapy|April 8, 2021
Early and Sustained Expansion of Adaptive Natural Killer Cells Following Haploidentical Transplantation and CTLA4Ig-Primed Donor Lymphocyte Infusions Dissociate Graft-versus-Leukemia and Graft-versus-Host EffectsSarita Rani Jaiswal, Sushmita Chakraborty, Rohit Lakhchaura, et al.
Transplantation and Cellular Therapy|April 8, 2021
Long-term Outcomes with Nonmyeloablative HLA-Identical Related Hematopoietic Cell Transplantation Using Tacrolimus and Mycophenolate Mofetil for Graft-versus-Host Disease ProphylaxisMasumi Ueda Oshima, Barry E Storer, Huiying Qiu, et al.
Transplantation and Cellular Therapy|April 8, 2021
Systematic Review/Meta-Analysis on Efficacy of Allogeneic Hematopoietic Cell Transplantation in Sickle Cell Disease: An International Effort on Behalf of the Pediatric Diseases Working Party of European Society for Blood and Marrow Transplantation and the Sickle Cell Transplantation International ConsortiumMadiha Iqbal, Tea Reljic, Selim Corbacioglu, et al.
Transplantation and Cellular Therapy|April 8, 2021
Immune Reconstitution Following TCRαβ/CD19-Depleted Hematopoietic Cell Transplantation for Hematologic Malignancy in Pediatric PatientsDanielle E Arnold, Derek MacMath, Alix E Seif, et al.
Transplantation and Cellular Therapy|April 8, 2021
Clostridioides difficile Infection and Risk of Acute Graft-versus-Host Disease among Allogeneic Hematopoietic Stem Cell Transplantation RecipientsRa'ed Jabr, Wissam El Atrouni, Leyla Shune, et al.
Pageof 183